Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00185874
Status:
TERMINATED
Last Update Posted:
2010-01-13
First Post:
2005-09-12
Brief Title:
Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
A Phase I Trial of Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases
Status:
TERMINATED
Status Verified Date:
2010-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Study closed due to lack of funding
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Up to twenty-two patients will be enrolled in this study to receive autologous dendritic cells DCs administered intratumorally into liver metastases following radiofrequency thermal ablation of those lesions Patients will receive two vaccinations of DCs at monthly intervals A dose escalation study of DCs will be included in this study in an attempt to define the maximum tolerated dose of administered DCs
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NIH 16766 | None | None | None |
| HEP0002 | None | None | None |
| NCT00185874 | None | None | None |